Overall, these results confirmed a high frequency of canonical PIK3CA mutations (substitutions H1047L and E542K, E545K, and E545D) in HNSCC, including in HPV (−) cases, suggesting that screening for PIK3CA mutations should not be restricted to HPV (+) patients. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.